Your browser doesn't support javascript.
loading
Combined Immunotherapy Improves Outcome for Replication-Repair-Deficient (RRD) High-Grade Glioma Failing Anti-PD-1 Monotherapy: A Report from the International RRD Consortium.
Das, Anirban; Fernandez, Nicholas R; Levine, Adrian; Bianchi, Vanessa; Stengs, Lucie K; Chung, Jiil; Negm, Logine; Dimayacyac, Jose Rafael; Chang, Yuan; Nobre, Liana; Ercan, Ayse B; Sanchez-Ramirez, Santiago; Sudhaman, Sumedha; Edwards, Melissa; Larouche, Valerie; Samuel, David; Van Damme, An; Gass, David; Ziegler, David S; Bielack, Stefan S; Koschmann, Carl; Zelcer, Shayna; Yalon-Oren, Michal; Campino, Gadi Abede; Sarosiek, Tomasz; Nichols, Kim E; Loret De Mola, Rebecca; Bielamowicz, Kevin; Sabel, Magnus; Frojd, Charlotta A; Wood, Matthew D; Glover, Jason M; Lee, Yi-Yen; Vanan, Magimairajan; Adamski, Jenny K; Perreault, Sebastien; Chamdine, Omar; Hjort, Magnus Aasved; Zapotocky, Michal; Carceller, Fernando; Wright, Erin; Fedorakova, Ivana; Lossos, Alexander; Tanaka, Ryuma; Osborn, Michael; Blumenthal, Deborah T; Aronson, Melyssa; Bartels, Ute; Huang, Annie; Ramaswamy, Vijay.
Afiliação
  • Das A; Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Canada.
  • Fernandez NR; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Canada.
  • Levine A; The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Canada.
  • Bianchi V; Department of Paediatric Haematology and Oncology, Tata Medical Center, Kolkata, India.
  • Stengs LK; Department of Paediatrics, University of Toronto, Toronto, Canada.
  • Chung J; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Canada.
  • Negm L; The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Canada.
  • Dimayacyac JR; Department of Paediatric Laboratory Medicine, The Hospital for Sick Children, Toronto, Canada.
  • Chang Y; Department of Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto, Toronto, Canada.
  • Nobre L; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Canada.
  • Ercan AB; The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Canada.
  • Sanchez-Ramirez S; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Canada.
  • Sudhaman S; The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Canada.
  • Edwards M; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Canada.
  • Larouche V; The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Canada.
  • Samuel D; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Canada.
  • Van Damme A; The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Canada.
  • Gass D; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Canada.
  • Ziegler DS; The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Canada.
  • Bielack SS; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Canada.
  • Koschmann C; The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Canada.
  • Zelcer S; Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Canada.
  • Yalon-Oren M; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Canada.
  • Campino GA; The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Canada.
  • Sarosiek T; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Canada.
  • Nichols KE; The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Canada.
  • Loret De Mola R; Institute of Medical Science, Faculty of Medicine, University of Toronto, Toronto, Canada.
  • Bielamowicz K; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Canada.
  • Sabel M; The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Canada.
  • Frojd CA; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Canada.
  • Wood MD; The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Canada.
  • Glover JM; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Canada.
  • Lee YY; The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Canada.
  • Vanan M; Pediatric Haematology/Oncology Department, CHU de Québec-Université Laval, Quebec City, Canada.
  • Adamski JK; Department of Paediatric Oncology, Valley Children's Hospital, Madera, California.
  • Perreault S; Department of Paediatric Haematology and Oncology, Saint Luc University Hospital, Université Catholique de Louvain, Brussels, Belgium.
  • Chamdine O; Atrium Health/Levine Children's Hospital, Charlotte, North Carolina.
  • Hjort MA; Kids Cancer Centre, Sydney Children's Hospital, Randwick, Australia.
  • Zapotocky M; School of Clinical Medicine, UNSW Sydney, Sydney, Australia.
  • Carceller F; Department of Pediatric Oncology, Hematology and Immunology, Center for Childhood, Adolescent, and Women's Medicine, Stuttgart Cancer Center, Klinikum Stuttgart, Stuttgart, Germany.
  • Wright E; Pediatric Hematology/Oncology, C.S. Mott Children's Hospital, University of Michigan, Ann Arbor, Michigan.
  • Fedorakova I; Department of Pediatrics, London Health Sciences Centre, London, Canada.
  • Lossos A; Department of Paediatric Haematology-Oncology, Sheba Medical Centre, Ramat Gan, Israel.
  • Tanaka R; Department of Paediatric Haematology-Oncology, Sheba Medical Centre, Ramat Gan, Israel.
  • Osborn M; Lux Med Onkologia, Warsaw, Poland.
  • Blumenthal DT; Department of Oncology, St Jude Children's Research Hospital, Memphis, Tennessee.
  • Aronson M; Oregon Health and Science University, Portland, Oregon.
  • Bartels U; Department of Pediatrics, Section of Pediatric Hematology/Oncology, The University of Arkansas for Medical Sciences/Arkansas Children's Hospital, Little Rock, Arkansas.
  • Huang A; Department of Paediatrics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg & Queen Silvia Children's Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Ramaswamy V; Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Cancer Discov ; 14(2): 258-273, 2024 Feb 08.
Article em En | MEDLINE | ID: mdl-37823831
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioma / Antineoplásicos Limite: Humans Idioma: En Revista: Cancer Discov Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioma / Antineoplásicos Limite: Humans Idioma: En Revista: Cancer Discov Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Canadá